Skip to content.

Spotlight

Our journey with Odin Vision

Our journey with Odin Vision

Read the article >

A computing impasse – the investments we make now will define our future

Read the article >
What's happening in biotech?

On not downclimbing – the prospects for early stage biotech remain bright

Read the article >

Why we invested in Carbon Re?

Read the article >

Bringing immuno-oncology cell therapies to the masses – are we (nearly) there yet?

Read the article >
Will the boom last?

A window to the past: is the investment boom in biotech going to last?

Read the article >
On the UK biotech public market

Over the Hill and (still) far away for UK biotechs

Read the article >

Why you should consider manufacturing from the start of the biotech R&D process

Read the article >
Platform technologies: going deep to go wide

Platform technologies: going deep to go wide

Read the article >
How to fund biotechs?

An evolution in early stage gene therapy funding models

Read the article >

An evolution in early stage gene therapy funding models

Read the article >

Why VC investing & rock climbing are more similar than you think

Read the article >